Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort study. - Tabuchi T; Taniki N; Ojiro K; Kasuga R; Nakadai Y; Chu PS; Usui S; Shiba S; Tahara T; Komatsu H; Fujita Y; Kaneko F; et al. (Frontiers in immunology, 2025)